$GLUE
Monte Rosa Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$10.55
▼-6.30%-$0.710
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMonte Rosa Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is GLUE down today? It is at $10.55 (-6.30%), and our scanner flagged it 66 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GLUE spikes, and full due diligence on GLUE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $GLUE 66 times in the last 30 days. Create a free account to track $GLUE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on GLUE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GLUE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on GLUE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GLUE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
GLUE last traded at $10.55, down 6.30% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Monte Rosa Therapeutics, Inc. Common Stock (GLUE) is next expected to report earnings on Thursday, November 5, 2026, about 32 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The GLUE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GLUE 66 times in the last 30 days.
GLUE (Monte Rosa Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $896M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GLUE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$GLUE discussion
Sign in to ask a question or join the discussion.